Posts by: Marisa Wexler MS

Marisa Wexler MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

February 5, 2019

ERT Helps Partially Restore Recycling Process in Cells from Gaucher, Fabry Patients, Study Shows

News

Enzyme replacement therapy (ERT) can help restore the normal organelle recycling processes that happen in cells, improving energy production in Gaucher and Fabry disease patients, a study has found. The ... Read more

January 22, 2019

Computer Simulation Identifies Treatments More Likely to Correct GBA Transport in Gaucher Patients, Study Says

News

A computer simulation — examining how some therapies interact with the two most common β-glucocerebrosidase (GBA) mutated forms in Gaucher disease — identified NN-DNJ and ambroxol as the most active treatments for correcting ... Read more

January 15, 2019

Researchers Develop 2 Stem Cell Lines from Skin Cells of Gaucher Disease Patients

News

Two new stem cell lines from patients with Gaucher disease have been developed and made available for studies, researchers report. The induced pluripotent stem cell (iPSC) lines — adult cells ... Read more

January 10, 2019

Case Report Describes First Patient with Both Gaucher Disease, Severe Congenital Neutropenia

News

A new case report describes an infant who presented with two rare blood cell diseases simultaneously: Gaucher disease (GD) and severe congenital neutropenia (SCN). This is the first reported case ... Read more

January 8, 2019

Study Shows Feasibility of Screening High-risk Gaucher Patients

News

A Canadian study shows that it is feasible to screen high risk patients — those with an enlarged spleen, low platelet levels, or both — for Gaucher disease in general ... Read more